Regulator Watch

Restrictive FDA legislation, swayed by to***co interests and abstinence-only advocates, creates barriers for alternative products seeking market approval. Consumers are increasingly turning to these products for harm reduction, but access is limited. ***coControl

Are 'anti-to***co' efforts actually helping cigarette companies? The reality might surprise you. Actions taken often boost sales and stock prices, especially when targeting va**ng and alternatives. It's time to question the narrative. ***co **ng